|
|
|
|
Vol. 59, Issue 3, 612-618, March 2001
Institut für Experimentelle und Klinische Pharmakologie und
Toxikologie, Universität Erlangen-Nürnberg, Erlangen,
Germany (S.A., C.K., H.G., A.P., H.U.Z.); and Division of Cell Biology,
Institute of Life Science, Kurume University, Fukuoka, Japan (H.T.)
Nociceptin/orphanin FQ (N/OFQ) and nocistatin (NST) are two
neuropeptides derived from the same precursor protein that exhibit opposing effects on spinal neurotransmission and nociception. Here, we
have used whole-cell, patch-clamp recordings from visually identified
neurons in spinal cord dorsal horn slices of genetically modified mice
to investigate the role of the N/OFQ receptor (N/OFQ-R) in the
modulatory action of both peptides on excitatory glutamatergic and
inhibitory glycinergic and
-aminobutyric acid (GABA)-ergic synaptic transmission. In wild-type mice, N/OFQ selectively suppressed excitatory transmission in a concentration-dependent manner but left
inhibitory synaptic transmission unaffected. In contrast, NST reduced
only inhibitory but not
-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)
receptor-mediated excitatory synaptic transmission. N/OFQ-mediated
inhibition of excitatory transmission was completely absent in N/OFQ-R
receptor-deficient (N/OFQ-R
/
) mice and significantly
reduced in heterozygous (N/OFQ-R+/
) mice, whereas the
action of NST on inhibitory neurotransmission was completely retained.
To test for the relevance of these results for spinal nociception, we
investigated the effects of intrathecally injected N/OFQ in the mouse
formalin test, an animal model of tonic pain. N/OFQ (3 nmol/mouse)
induced significant antinociception in wild-type mice, but had no
antinociceptive effects in N/OFQ-R
/
mice. These results
indicate that the inhibitory action of N/OFQ on excitatory
glutamatergic synaptic transmission and its spinal antinociceptive
action are mediated via the N/OFQ receptor, whereas the action of NST
is independent of this receptor.
This article has been cited by other articles:
![]() |
J. W. Lynch Molecular Structure and Function of the Glycine Receptor Chloride Channel Physiol Rev, October 1, 2004; 84(4): 1051 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. U. Zeilhofer and G. Calo Nociceptin/Orphanin FQ and Its Receptor--Potential Targets for Pain Therapy? J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 423 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, T. Kawashima, R. G. Allen, and H. Ueda Nocistatin and Prepro-Nociceptin/Orphanin FQ 160-187 Cause Nociception through Activation of Gi/o in Capsaicin-Sensitive and of Gs in Capsaicin-Insensitive Nociceptors, Respectively J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Moran and P. A. Smith Morphine-3beta -D-glucuronide Suppresses Inhibitory Synaptic Transmission in Rat Substantia Gelatinosa J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 568 - 576. [Abstract] [Full Text] [PDF] |
||||